Phil Gioia

President

Phil Gioia is President for Amring Pharmaceuticals, Inc. He is a highly experienced, passionate commercial leader with over 30 years of generic and branded pharmaceutical experience. He worked previously as Senior VP of Sales and Marketing for Generics with Barr Pharmaceuticals and was part of the team that built the Women’s Health proprietary business unit until its acquisition by Teva. Phil then led the NA Pharmaceutical Business followed by Global Head of Diversified Products and Business Development at Bausch & Lomb until its acquisition by Valeant.

Phil has extensive knowledge and demonstrated successes of business licensing, acquisitions, integrations and exits. He is also the co-founder of Vinci Pharmaceuticals, Inc., a specialty ophthalmic pharmaceutical company and a board advisor to several ophthalmology companies.

Phil holds a BS degree from Montclair State University (Marketing) and an MBA from Sacred Heart University.